{"id":"W2792512381","doi":"10.5489/cuaj.5187","title":"Kidney Cancer Research Network of Canada (KCRNC) consensus statement on the role of adjuvant therapy after nephrectomy for high-risk, non-metastatic renal cell carcinoma: A comprehensive analysis of the literature and meta-analysis of randomized controlled trials","year":2018,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"ca_institutions":"Dalhousie University; BC Cancer Agency; Princess Margaret Cancer Centre; Juravinski Cancer Centre; University of Manitoba; Ottawa Hospital; Université Laval; Centre Hospitalier de l’Université de Montréal; University of British Columbia; Centre Hospitalier Universitaire de Sherbrooke; McGill University; McGill University Health Centre; Jewish General Hospital; Sunnybrook Health Science Centre; McMaster University; University of Alberta; Université de Montréal","funders":"","keywords":"Medicine; Sunitinib; Pazopanib; Internal medicine; Sorafenib; Oncology; Vandetanib; Nephrectomy; Renal cell carcinoma; Hazard ratio; Kidney cancer; Adjuvant therapy; Placebo; Randomized controlled trial; Adjuvant; Cancer; Surgery; Confidence interval; Kidney; Pathology; Hepatocellular carcinoma; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.2012834,0.002527154,0.0134504,0.008973785,0.001970771,0.006441553,0.006536781,0.00542987,0.003299459],"category_scores_gemma":[0.2201827,0.001975404,0.01464614,0.01066902,0.002774362,0.00218495,0.003108414,0.005924843,0.0009636561],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01749898,"about_ca_system_score_gemma":0.09363628,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.1315974,"about_ca_topic_score_gemma":0.1658855,"domain_scores_codex":[0.8650811,0.08105348,0.02469594,0.005911544,0.0213082,0.00194974],"domain_scores_gemma":[0.6614804,0.1952029,0.03531926,0.007482777,0.09500199,0.005512696],"domain_codex":null,"domain_gemma":"methods","domain_candidate":"methods","domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.004682652,0.0001086121,0.0128083,0.3096866,0.09541211,0.000309799,0.0007634304,0.003955788,0.001416377,0.007789902,0.280626,0.2824404],"study_design_scores_gemma":[0.006749303,0.0007110349,0.02616261,0.4465172,0.1602671,0.0005357467,0.0004379705,0.00292451,0.00190554,0.02103727,0.3321127,0.0006390307],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001940027,0.8839102,0.006341608,0.08884402,0.006779255,0.001692233,0.007432451,0.0001182947,0.002942016],"genre_scores_gemma":[0.08269478,0.7486562,0.0671802,0.06971686,0.009025192,0.006651875,0.01262616,0.0004923862,0.002956324],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.982501,"threshold_uncertainty_score":0.9849598,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04624415173658525,"score_gpt":0.305409196986157,"score_spread":0.2591650452495718,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}